Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke

ConditionStroke
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara Yildirim Beyazıt University

About this trial

Purpose: The primary goal of this study is to investigate how different levels of upper extremity (arm) support affect walking patterns in individuals who have experienced a stroke. Specifically, the research aims to determine how restricting or facilitating arm swing during walking modulates spatiotemporal gait parameters (such as speed, step length, and rhythm).

Background: Arm swing plays a crucial role in maintaining balance, stability, and energy efficiency during normal walking. Following a stroke, many patients use walking aids (like canes or walkers) or clinical supports (like parallel bars) that restrict natural arm movement. This study examines whether these restrictions significantly alter gait mechanics in the stroke population.

Methodology: Participants will participate in a cross-over experimental trial. Each participant will walk on a specialized treadmill system (C-Mill VR+) under three randomized conditions: 1. Unsupported walking (no arm support), 2. Single-arm support (using the non-paretic side), 3. Dual-arm support (using both arms).

Researchers will record gait speed, step length, cadence, and duration of stance/swing phases for each condition.

Expected Outcome: The findings will provide scientific evidence on how different support strategies modulate walking performance. This information will help physical therapists design more effective, individualized rehabilitation programs to improve mobility and quality of life for stroke survivors.

Eligibility criteria

Qualifiers

Diagnosis of hemiplegia with ICD-10 code G.81.

Presence of unilateral hemiplegia.

No medical contraindications for the use of assistive devices (e.g., cane, tripod).

Aged 18 years or older.

Disqualifiers

Presence of aphasia.

Recurrent stroke.

Montreal Cognitive Assessment (MoCA) score below 10 points.

Trial design

Treatments tested in this trial

  • C-Mill VR+ (Force-plate integrated treadmill)
  • No Support Protocol
  • Unilateral Support Protocol
  • Bilateral Support Protocol

Treatment groups

34 Participants
are divided into 3 treatment groups